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Rapeseed oilBackground:ω-3 Long-chain polyunsaturated fatty acids (ω-3 LC-PUFA) are essential for an optimal development
of infants. An increased dietary intake of ω-3 PUFA may also be associated with a decrease in the vitamin E
content in the blood of healthy infants because these fatty acids have more isolated double bonds compared to
ω-6 PUFA and are therefore more susceptible to lipid peroxidation.
Methods: The present analysis is part of a randomised, food-based trial examining the inﬂuence of a 4–6-month
intervention with an increased content of ω-3 PUFA (sources: rapeseed oil or salmon) of complementary meals
on vitamin E concentration in plasma. From the introduction of complementary feeding at the age of 4–6months
until the age of 10 months, healthy infants born at term received vegetable–potato–meat meals either with
α-linolenic acid (ALA)-rich rapeseed oil (intervention group rapeseed oil, IG-R), salmon in combination with
corn oil (intervention group ﬁsh, IG-F) to provide docosahexaenoic acid (DHA), or with linoleic acid-rich corn
oil (control group, CG). Blood plasma was obtained at the 4th month ±14 days (age of infants at baseline) and
at the 10th month ±14 days (age of infants after 6 months of intervention) and analysed using HPLC (vitamin
E and malondialdehyde (MDA)) and GC (fatty acids). Vitamin E (tocopherol proﬁle) and MDA were measured
in plasma samples and fatty acids were determined in plasma glycerophospholipids.
Results: Complete data on vitamin E and fatty acid concentrations were available for 155 participants. Compared
to CG, IG-F and IG-R had higher weekly α-tocopherol equivalents (α-TE) intake (p b 0.05) and α-TE/PUFA ratio
(p b 0.05 (‘baby’ meals), p b 0.001 (‘junior’ meals)) by intake of complementary meals. At baseline and after
intervention, no signiﬁcant differences in vitamin E and MDA concentrations between IG-R, IG-F, and CG were
found inplasma. In all three groups, theα-tocopherol levels decreased after intervention (pb 0.001).With regard
to ω-3 PUFA, no differences at baseline existed. After intervention, infants of IG-F showed higher contents of
eicosapentaenoic acid (EPA), DHA and total ω-3 PUFA in plasma than CG, while the IG-R had higher levels of
ALA compared to CG.
Conclusions: The α-tocopherol supply decreased along with decreasing fat supply in the complementary feeding
period compared to breast milk and formula milk feeding period. The increase of ω-3 PUFA intake by comple-
mentary food (rapeseed oil or salmon) did not affect the vitamin E concentration in blood plasma of infants
compared to conventional complementary feeding with corn oil.
Clinical Trial Registration: www.clinicaltrials.gov, identiﬁer: NCT01487889, title: Polyunsaturated fatty acids in
child nutrition—a German multimodal optimisation study (PINGU).
© 2015 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license
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A healthy and balanced diet is a prerequisite for an optimal physical
and mental development of infants. Breast milk and vitamin E fortiﬁed
formula are the most important vitamin E sources for infants during
the ﬁrst 4–6 months. However, the vitamin E content in breast milk
depends on the maternal diet [1] and on the stage of lactation [2–7].
Starting between the 5th and 7th month, infants get vitamin E also by
complementary food while the supply from milk decreases. This fact is
important because the recommended intake of vitamin E increases-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
26 J. Kschonsek et al. / NFS Journal 3 (2016) 25–32after the 3rd month (4 mg α-tocopherol equivalents (TE) for infants
aged 4–12 months) [8].
One important function of vitamin E is to act as a radical scavenger
by inactivating reactive oxygen species (ROS). Thus, the oxidative stress
in the body can be reduced. Vitamin E is able to protect polyunsaturated
fatty acids (PUFA), which represent a major component of plasma lipo-
proteins and are also included in phospholipids of cell membranes,
against lipid peroxidation [9]. Thus, the physiological function of these
fatty acids can be guaranteed. Omega-3 PUFA (ω-3 PUFA) such as
docosahexaenoic acid (DHA) has been related to visual and cognitive
development in infancy [10–12]. They also have immune-modulating
properties and are functional parts of cell membranes [13–14]. There-
fore, the recommended daily intake for infants below the age of
24 months is 100 mg for ω-3 long-chain polyunsaturated fatty acids
(ω-3 LC-PUFA), mostly as eicosapentaenoic acid (EPA) and DHA)/day
[15]. Particularly, the long-chain metabolites EPA and DHA and arachi-
donic acid (ARA) are very susceptible to lipid peroxidation because of
their high number of isolated double bonds. Infants have a high demand
of LC-PUFA because of their rapid growth and are therefore also more
sensitive to oxidative stress. As a consequence, they also have a particu-
larly high demand of vitamin E [16]. For this reason, there is the risk that
modifying LC-PUFA intakewithout an adaption of vitamin Emay lead to
a decreased vitamin E concentration in blood plasma of healthy infants.
Past studies showed that LC-PUFA supplementation of the diet de-
creased the tocopherol/lipid ratio in the erythrocytes of infants and
the plasma vitamin E concentrations in adults, which was associated
with serious health risks, especially in newborns [17]. Thus, the analysis
of concentrations of vitamin E in plasma is of particular importance
to detect the potential inﬂuences of LC-PUFA supplies on the infants'
antioxidant status. As part of the PINGU study (‘Polyunsaturated
fatty acids in child nutrition—a German multimodal modiﬁcation
study’—coordinated by the Research Institute of Child Nutrition),
the aim of the present analysis was to examine the inﬂuence of modiﬁ-
cations of the LC-PUFA supply by a food-based approach in complemen-
tary meals on the vitamin E concentrations in blood plasma of healthy
infants after a 4–6 months feeding period.
2. Study details
2.1. Study design
The randomised controlled trial PINGU (ﬁeld period: June 2011
to August 2013; study location: Dortmund) examined the effects of
two approaches of dietary ω-3 PUFA modiﬁcation via complementary
meals on endogenous DHA status and on visual and cognitive develop-
ment in the second 6 months of life: a) ω-3 ALA-rich rapeseed oil to
enhance the endogenous DHA synthesis (intervention group rapeseed
oil, IG-R) or b) ﬁsh (salmon) as a source of preformed DHA twice a
week (intervention group ﬁsh, IG-F). The control group (CG) received
meals with corn oil, rich in ω-6 linoleic acid. Between IG-R and CG,
the study food only differed with respect to the added vegetable oil.
Mean rapeseed oil content of the study food in IG-R was 1.4 g per
100 g. IG-F received the same meals as the CG, except that two meat
meals per weekwere replaced by ﬁsh (salmon)meals. Weighed dietary
records were used to assess compliance (at 6 and 9 months of age) as
well as age at the introduction of complementary feeding and length
of intervention. The dietary intervention thus covered the period
of complementary feeding as generally recommended in Germany
(beginning: between the 5th and 7th month, ending: at the age
of 10 months) and also by European institutions (ESPGHAN, EFSA)
[18–19]. The intervention focused on vegetable–potato–meat meal
which is recommended to be introduced as ﬁrst complementary food
and is a central part of the dietary guidelines. Subsequently, two other
types of complementary meals (a milk-cereal meal and a cereal-fruit
meal) are introducedwhile keepingbreastmilk or formula as remaining
liquid milk part of the diet. The participating families in PINGU receiveddietary counselling by study personnel on the ‘Dietary schedule, irre-
spective of the study group’. This research used random allocation to
the study groups to take care that infants' diets only differed in the
study food.
Blood sampling for the investigation of fatty acids and vitamin E
status took place immediately before and after the intervention period
(T1: 4 months of age ±14 days, T2: 10 months of age ±14 days) at
the Paediatric Clinic Dortmund. For the present study, vitamin E homo-
logues contents were analysed in the interventionmeals (n= 24; eight
per group) and in blood samples of the infants (n = 163; sufﬁcient
sample material was available only for 155 participants). Parents
were instructed to use this meal once a day according to the study pro-
tocol and in line with the general guidelines for infant nutrition in
Germany. As infants were randomised into the 3 study groups, it can
be assumed that differences in vitamin E intake between the groups
resulted from differences in vitamin E intake from study food. Further
details of the study design are provided elsewhere [20]. The PINGU
study was conducted according to the guidelines laid down in the
Declaration of Helsinki. Informed written consent was obtained from
all mothers of the infants. The study protocol including justiﬁcation
and details on blood sampling procedures was reviewed and approved
(Ethical Vote no. 282/10) by the Ethical Committee of the Rheinische
Friedrich-Wilhelms-Universität Bonn at the Medical Faculty (Sigmund-
Freud-Str. 25, 53105 Bonn, Germany). The trial was registered at
clinicaltrials.gov (NCT01487889).2.2. Study food
Study foods were commercial vegetable–potato–meat or vegetable–
potato–ﬁsh meals (produced by HiPP GmbH & Co. Vertrieb KG,
Pfaffenhofen), common in the German market, with usual portion
sizes, i.e. ‘baby’ jars (190 g) intended for the age of 5–7 months and
‘junior’ jars (220 g) for the age of 8–12 months. All groups received
four different ‘baby’ and ‘junior’meals, respectively, to provide sufﬁcient
taste variety. The composition of themeals was the same except for the
added oil. In addition, IG-F replaced twice a week a meat meal with a
ﬁsh meal. The exact composition of the study food meals can be seen
in Table 1.3. Methods
3.1. Chemicals
Methyl-tert-butylether (MtBE) (Sauerbrey Chromatographie,
Reinhardshagen, Germany), n-hexane, methanol (VWR, Darmstadt,
Germany), o-phosphoric acid (Carl Roth, Karlsruhe, Germany) and
all other solvents used were of HPLC grade. Pure DL-α-, β-, γ-, and
δ-tocopherols (≥95%, analytical grade) were utilised from Calbiochem
(Darmstadt, Germany), pure DL-α-, β-, γ-, and δ-tocotrienols (≥97%,
analytical grade) from Davos Life Sciences (Singapore), the internal
standard α-tocopherol acetate (≥96%, analytical grade) from Sigma–
Aldrich (Taufkirchen, Germany) and the malondialdehyde standard
from Merck (Darmstadt, Germany). HPLC grade water (18 Mω) was
prepared using a Millipore Milli-Q puriﬁcation system (Millipore
GmbH, Schwalbach, Germany). Magnesium carbonate, sodium
sulphate, butylated hydroxytoluene (BHT), thiobarbituric acid and all
other chemicals used were of analytical grade.3.2. Standard preparation
Stock solutions of each tocopherol and tocotrienol standard were
prepared in ethanol and stored at−30 °C. The exact concentrations of
the stock solutions were determined spectrophotometrically at their
speciﬁc absorption maxima (see Table 2).
Table 1
Composition of several PINGU study food meals.
Study meals Ingredients
Baby meals
(5th–7th month)
Vegetable rice with organic chicken Vegetables 43% (carrots, peas, tomatoes), water, rice cooked 22%, chicken 8%, vegetable oil 1.7%, onions
Parsnips with potatoes and organic turkey Vegetables 73% (50% parsnips, potatoes 23%), water, turkey meat 8%, vegetable oil 1.5%
Carrots with potatoes and organic beef Vegetables 76% (carrots 47%, potatoes 29%), water, beef 8%, vegetable oil 1.3%
Spaghetti Bolognese Cooked vegetables 49% (24% tomato, carrots, parsnips), milled pasta (durum wheat) 21%, rice cooked, water,
5% Beef, onions, vegetable oil 1.7%, herbs (basil, oregano )
or: Early carrots with potatoes and salmon⁎ Vegetables 65% (carrots 45%, potatoes 20%), water, salmon 11%, rice cooked, corn oil 1%
Junior meals
(8th–10th month)
Potato and vegetable with organic beef Vegetables 62% (41% potatoes, carrots 21%), water, beef 8%, rice cooked, vegetable oil 1.65%, iodised salt
Organic ham noodles with vegetables Vegetables 36%, (carrots, tomatoes, corn), water, noodles cooked (durumwheat) 19%, hams and uncured 10.5%,
rice cooked, onions, vegetable oil 0.8%, iodised salt
Carrots pumpkin vegetable with organic veal Vegetables 60% (carrots 37%, potatoes 15%, pumpkin 8%), water, boiled rice, veal 8%, vegetable oil 1.4%, iodised salt
Tomato risotto with organic pig Vegetables 53% (34% tomato, parsnips, courgettes and peas), rice cooked 20%, water, 8% pork, onions,
vegetable oil 1%, iodised salt, herbs (basil)
or: Vegetable rice with salmon⁎ Vegetables 39% (15% carrots, parsnips, tomatoes, fennel 4%), water, rice cooked 21%, 12.5% salmon, onions,
lemon juice from lemon juice concentrate, iodised salt, corn oil 0.5%, spices and herbs (dill, pepper)
⁎ Only the intervention group ﬁsh (IG-F) has received these study meals with salmon instead of ‘spaghetti Bolognese’ and ‘tomato risotto with organic pig’ (twice a week).
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All examinations were performed under subdued light con-
ditions. All complementary meals were weighed (approximately
3 g) in an Erlenmeyer ﬂask. Magnesium carbonate and sodium sul-
phate for deacidiﬁcation and dewatering and 100 μl α-tocopherol
acetate (3.7·10−3 mol/l stock solution) as internal standard were
added to the samples. The samples were extracted with methanol/
tetrahydrofuran (1/1, v/v + 0.1% BHT) by homogenisation for 5 min
on ice using an ultra turrax (type T25, IKA-Werke, Staufen, Germany).
The extract was ﬁltered under vacuum through ﬁlter paper no. 390
(Filtrak, Niederschlag, Germany) on a Büchner funnel. This extraction
was repeated until colourlessness. The combined extracts were
rotary-evaporated under reduced pressure at 30 °C to a small volume.
The dried residues were dissolved in a volume of 10 ml MtBE. After
centrifugation (18,400 rcf, 5 min), an aliquot of the extract was dried
with nitrogen. The residue was dissolved in n-hexane/MtBE (98/2, v/m;
mobile phase of HPLC) and after a second centrifugation (16,000 rcf,
5 min), the samples were used for HPLC measurement.
3.4. Extraction of vitamin E in blood plasma
All examinations were performed under subdued light condi-
tions. Due to the small sample volumes, 200 μl of HPLC water were
added to the samples to increase volume. Proteins in plasma were
precipitated by adding 250 μl of a 1:125 dilution of α-tocopherol
acetate (3.7·10−3 mol/l stock solution) in EtOH (absolute). The sam-
ples were extracted with n-hexane (+0.1% BHT) by shaking on
vortex for 30 s. After centrifugation (510 rcf, 10 min), the upper
phase was collected. The extraction was repeated twice while in
the last extraction the centrifugation parameters were changed toTable 2
Molecular weights and absorption properties of tocopherols and tocotrienols.
Tocopherol/
tocotrienol
Molecular
weight
[g/mol]
Absorption
maximum in
ethanol λ [nm]
Extinction
coefﬁcient ε 1cm1%
[l/g·cm]
α-tocopherola 430.7 292 75.8
β-tocopherola 416.7 296 89.4
γ-tocopherola 416.7 298 91.4
δ-tocopherola 402.6 298 87.3
α-tocotrienola 424.7 293 91.0
β-tocotrienola 410.6 294 87.3
γ-tocotrienola 410.6 296 90.5
δ-tocotrienola 396.0 297 88.1
α-tocopherolacetateb 472.8 285 44.0
a [21].
b [22].16,000 rcf for 2 min. The combined extracts were dried with nitro-
gen. The residue was dissolved in n-hexane/MtBE (98/2, v/m).
After centrifugation (16,000 rcf, 5 min), the samples were used for
HPLC analysis.
3.5. Analysis of vitamin E
Tocopherols and tocotrienols were analysed using a ﬂuorescence
detector (excitation: 292 nm, emission: 330 nm) (F-1080 Merck
Hitachi, Darmstadt, Germany) according to the method of Werner
[22]. The column was a normal-phase Eurospher 100 Diol
(250 × 4.0 mm, 7 μm, Knauer, Berlin, Germany) and was heated to
35 °C. An injection volume of 20 μl was used. Elution was performed
using a mixture of n-hexane/MtBE (98/2, v/m) at a ﬂow rate of
1.5 ml/min, and the run time was 45 min. Calibration curves were
done for β-tocopherol and α-tocotrienol in the range 0.07·10−6–
9.7·10−6 mol/l, for α-tocopherol and β-tocotrienol 0.14·10−6–
17.3·10−6 mol/l, for δ-tocotrienol 0.38·10−6–19.1·10−6 mol/l, for
γ-tocopherol and γ-tocotrienol 0.17·10−6–22.3·10−6 mol/l and for
δ-tocopherol 0.22·10−6–28.1·10−6 mol/l. Tocopherols and tocotrienols
were identiﬁed and quantiﬁed by using external standards.
3.6. Determination and analysis of malondialdehyde in plasma
The determination of malondialdehyde (MDA) in plasma of infants
was performed by amodiﬁedmethod ofWong et al. [23]. For the extrac-
tion, 25 μl plasma of each infant were used. At ﬁrst, 375 μl o-phosphoric
acid (0.44 mol/l) and 125 μl thiobarbituric acid (42·10−3 mol/l) were
added to the samples. The mixture was heated for 1 h in a water bath
(95–100 °C) and then immediately cooled in an ice bath. This was
followed by a neutralisation with MeOH/NaOH (0.3 mol/l), mixing
100 μl of cooked sample with 100 μl MeOH/NaOH. After centrifugation
(13,800 rcf, 8 min, 4 °C), the samples were used for HPLC analysis.
MDA was analysed as MDA-thiobarbituric acid adducts using a
ﬂuorescence detector (excitation: 525 nm, emission: 550 nm) (RF-
10AXL Shimadzu, Kyōto, Japan). The column was a reversed-phase
Reprosil-Pur 120 C18-AQ, (250 × 4.6 mm, 5 μm, Dr. Maisch GmbH,
Ammerbuch, Germany) and was heated to 40 °C. An injection volume
of 20 μl was used. Elution was performed using a mixture of 40%
MeOH/60% 0.05 mol/l phosphate buffer (pH 6.8) at a ﬂow rate of
1.0 ml/min and the run time was 8 min. Calibration curve was done in
the range 0.20·10−6–2.02·10−6 mol/l.
3.7. Determination and analysis of fatty acid status in plasma
The fatty acid analysis in plasma glycerophospholipids (GP) was
performed as described by Glaser et al. [24]. Fatty acid methyl esters
(FAME) of plasma were quantiﬁed by GC (Agilent 7890, Waldbronn,
Table 3
Contents of vitamin E homologues and α-tocopherol equivalents [10−3 g/100 g] in study
food meals.
Study meals Vitamin E
homologue
Rapeseed
oil group
Fish
group
Corn oil
group
p
Baby meals (5th–7th month)
Vegetable rice
with organic
chicken
α-T 1.01 ± 0.03⁎ 0.83 ± 0.09 0.81 ± 0.03 b0.05
γ-T 0.80 ± 0.03⁎⁎ 1.24 ± 0.10 1.27 ± 0.03 b0.001
α-T3 0.05 ± 0.004⁎ 0.06 ± 0.01 0.07 ± 0.01 b0.05
γ-T3 0.03 ± 0.003⁎ 0.04 ± 0.01 0.07 ± 0.01 b0.05
α-TE 1.22 ± 0.04 1.16 ± 0.12 1.15 ± 0.04 0.484
Parsnips with
potatoes and
organic turkey
α-T 0.81 ± 0.04 0.83 ± 0.08 0.85 ± 0.13 0.867
γ-T 0.11 ± 0.01⁎ 0.14 ± 0.01 0.14 ± 0.02 b0.05
α-TE 0.84 ± 0.04 0.87 ± 0.08 0.88 ± 0.13 0.822
Carrots with
potatoes and
organic beef
α-T 0.69 ± 0.04⁎ 0.56 ± 0.04 0.59 ± 0.02 b0.05
γ-T 0.41 ± 0.03⁎ 0.62 ± 0.05 0.64 ± 0.02 b0.001
α-T3 0.05 ± 0.003 0.06 ± 0.01 0.06 ± 0.002 0.162
α-TE 0.81 ± 0.05 0.74 ± 0.05 0.77 ± 0.02 0.174
Spaghetti
bolognese or:
Early carrots
with potatoes
and salmon†
α-T 0.90 ± 0.08 1.41 ± 0.12⁎⁎ 0.84 ± 0.06 b0.001
γ-T 0.45 ± 0.03⁎⁎ 1.01 ± 0.08 1.13 ± 0.09 b0.001
α-T3 0.02 ± 0.001⁎ 0.08 ± 0.01⁎⁎ 0.04 ± 0.003 b0.001
β-T3 0.02 ± 0.003 n.d. 0.02 ± 0.002
γ-T3 0.02 ± 0.002 0.03 ± 0.003 0.03 ± 0.004 b0.05
α-TE 1.03 ± 0.08 1.68 ± 0.14⁎ 1.13 ± 0.08 b0.05
Junior meals (8th–10th month)
Potato and
vegetable with
organic beef
α-T 0.64 ± 0.09⁎ 0.31 ± 0.05 0.31 ± 0.02 b0.05
γ-T 0.50 ± 0.07 0.48 ± 0.07 0.46 ± 0.01 0.727
α-T3 0.02 ± 0.003 0.03 ± 0.01 0.03 ± 0.004 0.630
α-TE 0.77 ± 0.11⁎ 0.44 ± 0.07 0.43 ± 0.02 b0.05
Organic ham
noodles with
vegetables
α-T 0.52 ± 0.02⁎ 0.40 ± 0.03 0.38 ± 0.03 b0.05
γ-T 0.24 ± 0.01⁎⁎ 0.42 ± 0.01 0.40 ± 0.04 b0.001
α-T3 0.04 ± 0.001 0.05 ± 0.002 0.05 ± 0.004 0.991
β-T3 0.06 ± 0.004 0.06 ± 0.01 0.05 ± 0.01 0.729
γ-T3 0.04 ± 0.01 0.04 ± 0.01 0.05 ± 0.01 0.422
α-TE 0.60 ± 0.02⁎ 0.52 ± 0.03 0.50 ± 0.04 b0.05
Carrots with
pumpkin and
organic veal
α-T 0.50 ± 0.05⁎ 0.38 ± 0.03 0.40 ± 0.01 b0.05
γ-T 0.30 ± 0.04⁎ 0.20 ± 0.02 0.21 ± 0.02 b0.05
α-T3 0.04 ± 0.002 0.04 ± 0.01 0.04 ± 0.01 0.787
α-TE 0.59 ± 0.05⁎ 0.44 ± 0.03 0.46 ± 0.01 b0.05
Tomato risotto
with organic
pig or:
Vegetable rice
with salmon†
α-T 0.75 ± 0.08 1.18 ± 0.11⁎ 0.72 ± 0.07 b0.05
γ-T 0.36 ± 0.05⁎ 0.57 ± 0.03 0.58 ± 0.03 b0.05
α-T3 0.01 ± 0.002 0.03 ± 0.004 0.02 ± 0.003 0.796
γ-T3 0.04 ± 0.01 0.05 ± 0.004 0.04 ± 0.003 b0.05
α-TE 0.85 ± 0.09 1.33 ± 0.12⁎ 0.87 ± 0.07 b0.05
P values represent results from analysis of variance (ANOVA) following post-hoc-test
Dunnett with group afﬁliation as exposition variable.
T: tocopherols; T3: tocotrienols; α-TE: α-tocopherol equivalents.
⁎ p b 0.05.
⁎⁎ p b 0.001.
† Only the ﬁsh group has received these study meals with salmon instead of ‘spaghetti
bolognese’ and ‘tomato risotto with organic pig’ (twice a week).
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Mülheim, Germany) and a ﬂame ionisation detector using a BPX-70
column (60 m, 0.25 mm ID, SGE, Weiterstadt, Germany). Chromato-
graphic data were evaluated with Chemsation (Rev. B.03, Agilent,
Waldbronn, Germany). Further details can be seen in the publication
of Libuda et al., who determined and analysed the fatty acid data. [25].
3.8. Statistical analysis
The data are expressed as means ± standard deviations (SD). The
vitamin E data were analysed using SPSS procedures (version 22.0, Sta-
tistical Package for the Social Sciences, Chicago, USA). P values b 0.05
were considered as signiﬁcant. Those data of vitamin E which were
below the detection limit were included in the statistical evaluation
with half of the detection limit. The homogeneity of variances for all
data was assumed by Levene test. The one-factorial analysis of variance
(ANOVA) was used following the Dunnett procedure for assessing
group differences in study sample characteristics. Time point effects of
vitamin E and MDA were analysed with paired t-tests. In addition,
group and time point differences were analysed with the repeated-
measures ANOVA. The statistical analysis of the fatty acids data was
performed using SAS® procedures (version 9.2, Statistical Analysis
Systems, Cary, NC, USA). P values b 0.05 were considered as signiﬁcant.
ANOVA was used for assessing group differences in study sample char-
acteristics for continuous variables and chi-square test for categorical
variables. Intervention effects on fatty acid status were examined
using the analysis of covariance (ANCOVA) with the respective fatty
acid parameter at T2 as outcome. Further details can be seen in the pub-
lication of Libuda et al. [25]. In general, subjects with complete data of
vitamin E status and fatty acid status (T1 and T2)were examinedwithin
their randomised group.
4. Results
4.1. Vitamin E contents of complementary meals and vitamin E intake
The vitamin E contents of 24 complementary meals (eight per
group) were determined. The food composition of the complementary
meals differed between the study groups only with regard to the vege-
table oil (rapeseed oil or corn oil) used and the exchange of meat vs.
salmon twice a week in the IG-F group. In all study groups, tocopherol
contents in the study meals were higher than tocotrienol contents.
The study meals contained α- and γ-tocopherol and α-, β-, and
γ-tocotrienol, while contents of β- and δ-tocopherol and δ-tocotrienol
were below the detection limit. Within the study groups, the comple-
mentary meals differed in the α- and γ-tocopherol contents, due to
the individual recipes (Table 3).
The weekly α-TE intake with the complementary meals was signiﬁ-
cantly different between the three study groups (p b 0.05) because the
proportions of α- and γ-tocopherol differed. Meals with rapeseed oil
provided a signiﬁcantly higher α-tocopherol concentration (0.50 ±
0.05–1.01 ± 0.03·10−3 g/100 g) compared to the meals with corn oil
(0.31 ± 0.02–0.85 ± 0.13·10−3 g/100 g). In contrast, the meals with
corn oil delivered a signiﬁcantly higher concentration of γ-tocopherol
(0.14 ± 0.02–1.27 ± 0.03·10−3 g/100 g) compared to the meals with
rapeseed oil (0.11 ± 0.01–0.80 ± 0.03·10−3 g/100 g) due to different
tocopherol patterns of the oils. The meals with salmon, which also
contained corn oil, had the signiﬁcantly highest concentration of
α-tocopherol (1.41 ± 0.12·10−3 g/100 g (‘baby’ meals) and 1.18 ±
0.11·10−3 g/100 g (‘junior’meals)). The addition of two salmon meals
per week led to an increase of the mean α-tocopherol content in IG-F
from 0.59± 0.22·10−3 g/100 g to 0.67 ± 0.32·10−3 g/100 g compared
to CG while the γ-tocopherol content was affected only slightly. The
tocotrienols were found only sporadically in some meals and had very
low concentrations (≤0.08·10−3 g/100 g).Theweeklyα-TE/PUFA ratio (complementarymeals) was signiﬁcant-
ly different between the three groups in the ‘baby’ jars (p b 0.05) as well
as in the ‘junior’ jars (p b 0.001). Especially IG-R and IG-F, which con-
sumed more ω-3 PUFA, had a signiﬁcantly higher α-TE/PUFA ratio com-
pared to CG (Table 4).
4.2. Vitamin E and malondialdehyde concentration of blood plasma
The vitamin E concentration in plasma of 155 out of 163 infants was
investigated. Amounts of samplematerial were insufﬁcient for a triplicate
or duplicate analysis in eight participants. α- and γ-Tocopherol were de-
termined prior to and after intervention. The concentration of α-
tocopherol dominatedwith a proportion of 97%.No signiﬁcant differences
in the α- and γ-tocopherol contents existed between the three groups
prior to and after intervention (Table 5). The α-tocopherol
concentrations in blood plasma decreased signiﬁcantly (p b 0.001) by
14.4-16.5% in all three groups during the intervention, whereas the
content of γ-tocopherol solely increased (p b 0.05) in CG (Table 6).
Considering the concentrations of cholesterol and triglycerides in
plasma, no differences were found between the intervention groups and
Table 4
Estimated intake ofα-tocopherol equivalents, PUFA and total fat perweek from study food
in the 3 study groups of the PINGU study (one jar per day).
Estimated intake per week
[10−3 g]
Rapeseed oil
group
Fish
group
Corn oil
group
Baby jars (5th–7th month of life, 190 g/jar)
α-TE 10.9 14.2 11.0
DHA 3.2 297.1 3.2
EPA 3.2 819.6 3.2
AA 44.2 44.7 34.8
ALA 1454.6 866.2 467.5
LA 6171.6 10723.8 11677.8
PUFA 8412.3 12283.5 12302.5
Total fat 31920.0 34057.5 32252.5
Ratio α-TE: PUFA 1.30 1.16 0.90
Junior jars (8th–10th month of life, 220 g/jar)
α-TE 10.8 12.0 8.7
DHA 3.4 370.3 4.0
EPA 4.0 1019.1 4.0
AA 36.5 49.3 37.0
ALA 1521.2 860.2 488.8
LA 6030.7 10950.8 10723.8
PUFA 7738.5 14808.8 12878.3
total fat 39847.5 40260.0 40040.0
ratio α-TE: PUFA 1.40 0.82 0.68
The fatty acid data were analysed and determined by Libuda et al. [25].
T: tocopherol; TE: tocopherol equivalents; DHA: docosahexaenoic acid; AA: arachidonic
acid; ALA: alpha-linolenic acid; LA: linolenic acid; PUFA: polyunsaturated fatty acids.
Table 6
Vitamin E and MDA before and after 6 months of intervention [10−6 mol/l].
Group
afﬁliation
Intervention
groups
T1
(4 months of age)
T2
(10 months of age)
p
α-T Rapeseed oil 37.2 ± 8.9 31.1 ± 6.7 b0.001
Fish 36.6 ± 6.9 30.8 ± 6.9 b0.001
Corn oil 35.5 ± 7.1 30.4 ± 7.5 b0.001
γ-T Rapeseed oil 1.1 ± 1.1 1.3 ± 0.8 0.410
Fish 1.2 ± 1.3 1.3 ± 0.7 0.467
Corn oil 1.2 ± 1.5 1.6 ± 1.2 b0.05
∑Vitamin E Rapeseed oil 38.3 ± 9.1 0.65 ± 0.16 b0.001
Fish 37.8 ± 7.2 0.76 ± 0.37 b0.001
Corn oil 36.7 ± 7.6 0.69 ± 0.22 b0.001
MDA Rapeseed oil 0.80 ± 0.28 0.65 ± 0.16 b0.05
Fish 0.76 ± 0.22 0.76 ± 0.37 0.931
Corn oil 0.76 ± 0.26 0.69 ± 0.22 0.052
P values represent results from paired t-test (per intervention group) to evaluate differ-
ences between T1 (baseline) and T2 (after 6 months of intervention).
T: tocopherol; MDA: malondialdehyde.
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in triglycerides content. Thus, the signiﬁcant decreases (p b 0.001) of the
α-tocopherol/cholesterol ratio and the α-tocopherol/triglycerides ratio
were only dependent on the decrease of α-tocopherol.
In addition to vitamin E, the oxidative stress marker MDA was
analysed in plasma of infants. The MDA contents of IG-R and IG-F did
not differ signiﬁcantly in comparison with CG prior to and after the
intervention (Table 5). After 4–6 months of consumption of comple-
mentary food, there was no increase of the MDA concentrations in allTable 5
Comparison of parameters estimated in infants participating in the PINGU study (means ± SD
Group afﬁliation T1 (4 months of age)
Rapeseed oil
(n = 53)
Fish
(n = 46)
C
(
[10−6 mol/l] α-T 37.2 ± 8.9 36.6 ± 6.9 3
γ-T 1.1 ± 1.1 1.2 ± 1.3
∑Vitamin E 38.3 ± 9.1 37.8 ± 7.2 3
[10−6 mol/l] MDA 0.80 ± 0.28 0.76 ± 0.22 0
[10−3 mol/l] Cholesterol 3.8 ± 0.7 4.0 ± 0.9
Triglyceride 2.3 ± 0.9 2.1 ± 0.8
Ratios
α-T/cholesterol 10.0 ± 2.2 9.3 ± 1.5
α-T/triglyceride 19.0 ± 8.2 19.8 ± 9.1 1
[g/100 g] ALA 0.33 ± 0.15 0.29 ± 0.13 0
EPA 0.44 ± 0.16 0.44 ± 0.21 0
DHA 4.4 ± 1.2 4.4 ± 1.2
AA 10.5 ± 2.0 10.5 ± 2.0 1
LA 23.0 ± 2.9 22.9 ± 2.9 2
∑ω-3 PUFA 5.9 ± 1.4 6.0 ± 1.4
∑ω-3 LC-PUFA 5.6 ± 1.4 5.7 ± 1.4
Ratios
∑ω-3 LC-PUFA:∑ω-6 LC-PUFA 0.41 ± 0.09 0.41 ± 0.10 0
∑ω-3 PUFA:∑ω-6 PUFA 0.16 ± 0.04 0.16 ± 0.04 0
P values represent results fromanalysis of variance (ANOVA)with group afﬁliation as exposition
point).
Fatty acid differenceswere testedby analysis of covariance (ANCOVA) generally including group
in order to evaluate intervention effects.
The fatty acid data were analysed and determined by Libuda et al. [25].
T: tocopherol; MDA: malondialdehyde; DHA: docosahexaenoic acid; EPA: eicosapentaenoic ac
⁎ p b 0.05.
⁎⁎ p b 0.001.three groups. In IG-R, even a signiﬁcant decrease of the MDA content
(p b 0.05) was found (Table 6).
4.3. Fatty acids concentration of glycerophospholipids in plasma
Intervention effects considering potential differences in fatty acid
composition are presented in Table 5. In comparison with CG, the ALA
levels were higher in IG-R. No differences in DHA were observed
between IG-R and CG. In contrast, in IG-F, levels of EPA and DHA as
well as the sum of all analysed ω-3 LC-PUFAs in plasma were substan-
tially higher than in CG. Further details can be seen in the publication
of Libuda et al. [25].
5. Discussion
This is the ﬁrst study which investigated the effects of a food based
modiﬁcation of LC-PUFA concentration in complementary meals on) between groups.
p T2 (10 months of age) p
orn oil
n = 56)
Rapeseed oil
(n = 53)
Fish
(n = 46)
Corn oil
(n = 56)
5.5 ± 7.1 0.529 31.1 ± 6.7 30.8 ± 6.9 30.4 ± 7.5 0.894
1.2 ± 1.5 0.990 1.3 ± 0.8 1.3 ± 0.7 1.6 ± 1.2 0.125
6.7 ± 7.6 0.572 32.3 ± 7.0 32.1 ± 7.1 32.0 ± 8.1 0.976
.76 ± 0.26 0.721 0.65 ± 0.16 0.76 ± 0.37 0.69 ± 0.22 0.119
3.9 ± 0.7 0.530 4.0 ± 0.7 4.0 ± 0.6 3.9 ± 0.7 0.694
2.3 ± 1.2 0.742 1.8 ± 0.8 1.8 ± 1.2 1.9 ± 1.2 0.881
9.4 ± 1.8 0.249 8.2 ± 1.8 7.9 ± 1.3 8.0 ± 1.9 0.816
8.8 ± 9.0 0.859 16.6 ± 8.1 16.7 ± 6.8 16.5 ± 8.7 0.992
.29 ± 0.12 0.356 0.41 ± 0.13⁎⁎ 0.37 ± 0.16 0.31 ± 0.13 b0.05
.47 ± 0.23 0.659 0.35 ± 0.12 0.68 ± 0.35⁎⁎ 0.34 ± 0.15 b0.001
4.3 ± 1.3 0.941 3.0 ± 1.1 4.5 ± 1.1⁎⁎ 3.2 ± 1.2 b0.001
0.5 ± 2.3 0.994 8.4 ± 1.6 8.1 ± 1.6 8.4 ± 1.7 0.692
3.0 ± 3.2 0.985 26.3 ± 2.7 25.9 ± 2.4⁎ 26.9 ± 2.6 0.114
5.9 ± 1.5 0.953 4.6 ± 1.2 6.5 ± 1.3⁎⁎ 4.6 ± 1.4 b0.001
5.6 ± 1.6 0.955 4.2 ± 1.2 6.2 ± 1.4⁎⁎ 4.3 ± 1.4 b0.001
.41 ± 0.10 0.916 0.36 ± 0.09 0.58 ± 0.16⁎⁎ 0.37 ± 0.11 b0.001
.16 ± 0.04 0.960 0.12 ± 0.04 0.18 ± 0.04⁎⁎ 0.12 ± 0.04 b0.001
variable to evaluate general cross-sectional differences between all study groups (per time
afﬁliation and the baseline value of the respective outcomevariable as exposition variables
id; AA: arachidonic acid; ALA: alpha-linolenic acid; LA: linoleic acid.
30 J. Kschonsek et al. / NFS Journal 3 (2016) 25–32the plasma vitamin E concentration in healthy infants aged 4 months.
Although the α-tocopherol intake with the PINGU complementary
meals was signiﬁcantly higher in IG-R and IG-F compared to CG, the
α-tocopherol concentrations decreased in blood plasma of all three
groups. In general, it can be assumed that higher LC-PUFA content
leads to an increase of ROS, which is associated with higher MDA levels
and decreased antioxidant status [26]. However, theMDA levels in plas-
ma did not differ signiﬁcantly between IG-R, IG-F and CG. Contrary to
the assumption that the α-tocopherol content decreases by increased
oxidative stress (through ω-3 PUFA and ω-3 LC-PUFA), no differences
between the three groups were found (Table 5). The increased ω-3
PUFA content in IG-R and IG-F did not lead to a higher decrease in
plasmaα-tocopherol concentration compared to CG. Thus, themodiﬁed
fatty acid compositions of complementarymeals, using rapeseed oil and
salmon, showed no adverse effects on the vitamin E concentrations in
blood plasma of infants compared to meals with corn oil. This is impor-
tant in view of the fact that consumption of complementary food with
salmon twice a week was effective in maintaining plasma DHA levels
up to the age of 10 months, whereas the complementary food with
rapeseed oil insteadof corn oilmaintainedALA but not DHAblood levels
(Table 5) [25].ω-3 LC-PUFA such asDHAhave been related to visual and
cognitive development in infancy [10–12] because they are a part of the
greymatter (brain) and the retina of the eye [27]. Therefore, higher DHA
levels in plasma after intervention could improve the development of
infants in IG-F regarding visual and nervous system. Some other studies
also investigated the effects of ω-3 PUFA on α-tocopherol concentra-
tions for infants. The study population consisted of premature or full-
term infants mostly with low birth weight (≤1800 g). Demmelmair
et al. [17] found no signiﬁcant differences in the α-tocopherol content
between the supplemented group with LC-PUFA and the control
group after an intervention period of 4 weeks. The same result was ob-
tained by González-Corbella et al. [16] who observed 49 infants over a
period of 3 months. Speciﬁcally, they studied the effect of LC-PUFA
enriched formula milk on the α-tocopherol contents in blood plasma
and erythrocytes. There are even two studies which were able to dem-
onstrate an increase in α-tocopherol content. In these studies of
Koletzko et al. [28] and Decsi and Koletzko [29], 27 or 22 infants
received enriched LC-PUFA formula milk or a standard formula milk
over a period of 21 days or 4 months. No differences in oxidative stress
(MDA in plasma) between all three groups (IG-F, IG-R and CG) were
found, which may be explained by non-existing differences in the
α-tocopherol content (plasma) in these groups. A reason for this fact
could be the signiﬁcantly higherα-TE/PUFA ratio in the complementary
meals of IG-F and IG-R (p b 0.05 ‘baby’ meals and p b 0.001 ‘junior’
meals) compared to CG (Table 4).
The signiﬁcantly lower α-tocopherol contents in plasma of the
infants after 6 months of dietary intervention (Table 6) could be
explained with the high demands of vitamin E, which is important
for strong growth in the second half year of life. The German Nutri-
tion Society (DGE) recommends an intake of 4 mg α-TE per day
(=4 mg α-tocopherol) for infants from the 4th month of age for
protection of the double bonds formed during metabolic processes
in the body [8]. One PINGU complementary meal per day, being
only a part of the daily diet, provided already an α-TE supply of
0.74 ± 0.05·10−3 g/100 g to 1.68 ± 0.14·10−3 g/100 g (‘baby’
meals) or 0.43 ± 0.02·10−3 g/100 g to 1.33 ± 0.12·10−3 g/100 g
(‘junior’ meals) (Table 3). Syväoja et al. [30], who analysed comple-
mentary meals, especially fruit berry meals and meat vegetable
meals, noted a lower α-TE content of 0.46·10−3 g/100 g and
0.38·10−3 g/100 g of α-TE as compared to the PINGU meals. Thus,
some of the typical complementary meals in infant diet do not deliv-
er high vitamin E contents. Especially the ‘junior’ meals (exception:
the meal ‘vegetable rice with salmon’) provided a lower α-TE
supply compared to breast milk respectively formula milk with
0.59± 0.33·10−3 g/100ml to 1.00± 0.30·10−3 g/100ml [31]. In ad-
dition, the consumed amount during the breast milk or formula milkfeeding period during the ﬁrst months of life is higher (ca. 800 ml
milk per day) than the remaining milk part in the complementary
feeding period (from the 5th month 1 × 180 g complementary
meal, up to the 8th month and onwards 3 × 200 g complementary
meals). Thus, the weekly supply of vitamin E (as α-TE) with the
type of complementary meals is insufﬁcient to maintain the levels
of vitamin E in plasma during the period of complementary feeding
compared to the period of breast milk feeding. The low fat content
of the complementary meals compared to breast milk and formula
milk (approx. 50 energy%) can also be a reason for a decrease in α-
tocopherol concentration. Total fat content in complementary
meals is restricted to a maximum of 40 energy% in the EU
(Table 4). However, the fat intake is essential for digestion and ab-
sorption of lipophilic vitamins such asα-tocopherol [32]. In addition,
breast milk has breast milk lipase which stimulates the secretion of
bile acids in the infants and thus supports the digestion
of triglycerides and lipophilic vitamins [33–34]. Furthermore, the
long-chain fatty acids in the complementary meals may reduce the
absorption of α-tocopherol, because they were able to inhibit the
formation of micelles. In contrast, short and medium chain fatty
acids, which are abundant in breast milk [35], facilitate the vitamin
E absorption [36]. Therefore, a higher consumption of PUFA in com-
bination with an insufﬁcient supply of vitamin E can perhaps explain
the decrease of the α-tocopherol concentration in blood plasma
of the infants after the 4–6 months study period. A plasma α-
tocopherol concentration of b11.6·10−6 mol/l suggests a vitamin E
deﬁciency, while a concentration ≥80·10−6 mol/l is associated
with toxicity [37]. Although the concentration of α-tocopherol in
blood plasma has decreased in all three groups, there is no risk for
a vitamin E deﬁciency in the infants.
Another ﬁnding is that the α-TE intake and the resulting contents
of α- and γ-tocopherol in blood plasma can be inﬂuenced by the
choice of complementary meals because the meals provide different
amounts of vitamin E regardless of the oil (rapeseed vs corn oil) and
the replacement of salmon instead of meat. Whileα-tocopherol con-
centration is similar in both types of oil (13.0–24.0·10−3 g/100 g vs.
11.2–25.7·10−3 g/100g), γ-tocopherol concentration is higher in
corn oil (44.0–89.4·10−3 g/100 g) than in rapeseed oil (21.8–
48.6·10−3 g/100 g) [38–43]. The content of tocopherols may vary
because plants underlie natural variations such as climate and location
or time of harvest [44–45]. Because only the CG received corn oil, the
γ-tocopherol content in plasma increased signiﬁcantly, which can be
attributed to the increased intake of γ-tocopherol with corn oil.
Lemcke-Norojärvi et al. showed in healthy Swedish women that a sup-
plementation with corn oil or sesame oil (both rich in γ-tocopherol)
was associated with higher γ-tocopherol levels in blood serum [46].
Bieri and Evarts also found that, after feeding rats with soy oil or
corn oil, the γ-tocopherol content was largely dependent on the
γ-tocopherol intake [47]. This fact was already observed in the popula-
tion of the United States who prefer a high consumption of soy oil
[48–49]. In addition to CG, IG-F had almost the same dietary amount
of γ-tocopherol by consuming salmon meals. The concentration of
γ-tocopherol in salmon varies from 0.02–1.0·10−3 g/100 g because of
biological variations due to differences in feeding as well as seasonal
effects [50–54]. However, no signiﬁcant increase of γ-tocopherol in
blood plasma of IG-F could be detected. One possible reason could be
the higher intake of α-tocopherol compared to the CG. Wolf postulated
that an increased α-tocopherol intake is associated with the reduction
of γ-tocopherol content in blood plasma, which is due to the faster
metabolism and the associated excretion of γ-tocopherol [55]. Recent
animal experiments in mice showed the competition for SR-B1 recep-
tors in the gut being responsible for the decrease of γ-tocopherol con-
centration in blood plasma when increasing α-tocopherol intake [56].
The tocotrienols were found only sporadically in some meals and had
very low concentrations (≤0.08·10–3 g/100 g). They originated mainly
from cereals such as rice and noodles [57–58].
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Future studies should measure, in addition to MDA, more oxidative
stress markers (such as oxidative LDL) to analyse the prooxidative and
antioxidative balance. Also shorter measurement time points are
important to see rapid changes in the blood. For a more detailed
assessment of the vitamin E status, additional indicators should be used,
for example, the vitamin E content in thrombocytes. Platelet vitamin E
concentrations do not passively reﬂect plasma lipid changes and are
postulated to be better indicators of vitamin E nutritional status [59].
7. Conclusion
The modiﬁed fatty acid composition of complementary meals, using
rapeseed oil and salmon, showed no adverse effects on the vitamin E con-
centration (regarding to higher oxidative stress) in blood plasma of in-
fants compared to meals with corn oil (being poor in ω-3 fatty acids),
because the meals with rapeseed oil, respectively, salmon have a higher
α-TE/PUFA ratio. However, the weekly supply of vitamin E (as α-TE)
with the type of complementary meals is insufﬁcient to maintain the
levels of vitamin E during the period of complementary feeding. As al-
ready emphasised, oils are the main sources of vitamin E in complemen-
tary meals, especially in the PINGU meals. Therefore, oil content in
complementary meals needs to be increased or vitamin E forms should
be added like RRR-α-tocopherol acetate, which is already used in formula
and is already approved as a nutrient (Directive 2006/125/EG Commis-
sion Decision of 5 December 2006 on processed cereal based foods for in-
fants and young children). In this way, the vitamin E content can be
increased and a better vitamin E supply of infants can be guaranteed.
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